Timothy C. Ryken

University of Iowa Hospitals and Clinics — United States

Medicine · Health Sciences

69h-index15.7kcitations242works10.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(61), Spine and Intervertebral Disc Pathology(57), Spinal Fractures and Fixation Techniques(57), Brain Metastases and Treatment(33), Cervical and Thoracic Myelopathy(21)

Publications242 total

Establishing a Gold Standard for Noninvasive Identification of Painful Lumbar Discs: Prospective Comparison of Magnetic Resonance Spectroscopy vs Low-Pressure Provocation Discography
The International Journal of Spine Surgery·2024· 10 citedOpen Access
Examining barriers to implementing a surgical-site infection bundle
Infection Control and Hospital Epidemiology·2023· 21 citedOpen Access
Supplementary Figure S2 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S1 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Data from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S1 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S4 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Data from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S2 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figures Legends from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figures Legends from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S3 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S4 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S3 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Table 2 from Sample Type Bias in the Analysis of Cancer Genomes
2023Open Access
Data from Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
2023Open Access
Supplementary Data from Genome-Wide Analysis of Epigenetic Silencing Identifies <i>BEX1</i> and <i>BEX2</i> as Candidate Tumor Suppressor Genes in Malignant Glioma
2023Open Access
Data from Genome-Wide Analysis of Epigenetic Silencing Identifies <i>BEX1</i> and <i>BEX2</i> as Candidate Tumor Suppressor Genes in Malignant Glioma
2023Open Access
Data from Sample Type Bias in the Analysis of Cancer Genomes
2023Open Access
Supplementary Table Legends 1- 3 from Sample Type Bias in the Analysis of Cancer Genomes
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Jeffrey J. Olson(13), Beverly C. Walters(12), Mark N. Hadley(12), R. John Hurlbert(12), Sanjay S. Dhall(12), Daniel E. Gelb(12), Nicholas Theodore(12), Steven N. Kalkanis(12), Bizhan Aarabi(11), Curtis J. Rozzelle(11), Michael W. Groff(7), Mark E. Linskey(7), David W. Andrews(7), Anthony L. Asher(7), Stuart H. Burri(7), Douglas Kondziolka(7), Paula D. Robinson(7), Charles Cobbs(7), Laurie E. Gaspar(7), Jay S. Loeffler(7)